Science Corporation Completes $400 Million Series D Financing
Understand this story
Science Corporation, a medical technology company founded by former Neuralink president Max Hodak, has completed a $400 million Series D financing round, reaching a company valuation of $3.5 billion. The news was announced by the company in a blog post. Investors in this round include Khosla Ventures, Y Combinator, and others. Science Corporation was founded in 2021 and focuses on the medical technology field.
AI overview based on source reports · Updated 11 hr ago
Coverage timeline
Follow the coverage to explore different perspectives.
- TechCrunch · AIScience Corporation’s brain tech is worth $3.5 billion after new funding
Science Corporation, the medical technology startup founded in 2021 by former Neuralink president Max Hodak, raised a $400 million Series D at a $3.5 billion valuation, with backers including Khosla Ventures, Y Combinator, and Tenet Healthcare. Its first product, PRIMA, a wearable and implantable chip that helps people with age-related macular degeneration recover some vision, is approved in Europe and available in Germany, and is now being trialled for Stargardt's disease. The company aims to bring the device to the US through the FDA's Humanitarian Device Exemption, while pursuing its founding goal of a bio-hybrid sensor combining cultured neurons and silicon, with initial human trials being designed with Yale neurosurgery professor Murat Günel.
Activity for this story
- Current comparable activity
- 7
- Peak comparable activity
- 10Nov 17 23:00
- Change in the past 24 hours
- –
Trends compare the same fully observed participants, which may cover fewer participants than current activity. Move the pointer or tap the chart to inspect hourly activity; use the left and right arrow keys with a keyboard.